AstraZeneca U.S. trial data a confidence booster for COVID-19 shot

AstraZeneca's COVID-19 vaccine performed better than expected in a major late-stage trial potentially paving the way for its emergency authorization in the United States and bolstering confidence in the shot after numerous setbacks in Europe.